Harrow Will Release Third Quarter 2023 Financial Results on November 13, 2023
Conference Call Details: |
|
Date: |
Monday, November 13, 2023 |
Time: |
4:45 p.m. Eastern time |
Participant Dial-in: |
1-833-953-2434 ( |
Replay Dial-in (Passcode 7225453): (telephonic replay through November 20, 2023) |
1-877-344-7529 ( |
Webcast: (online replay through November 13, 2024) |
About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the U.S. market. Harrow helps
View source version on businesswire.com: https://www.businesswire.com/news/home/20231030960332/en/
Jamie Webb
Director of Communications and Investor Relations
jwebb@harrowinc.com
615-733-4737
Source: Harrow, Inc.